17-34287602-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002986.3(CCL11):c.206C>A(p.Ala69Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000521 in 1,613,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002986.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL11 | NM_002986.3 | c.206C>A | p.Ala69Asp | missense_variant | 3/3 | ENST00000305869.4 | NP_002977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL11 | ENST00000305869.4 | c.206C>A | p.Ala69Asp | missense_variant | 3/3 | 1 | NM_002986.3 | ENSP00000302234 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152008Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251300Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135818
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461514Hom.: 0 Cov.: 30 AF XY: 0.0000605 AC XY: 44AN XY: 727092
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.206C>A (p.A69D) alteration is located in exon 3 (coding exon 3) of the CCL11 gene. This alteration results from a C to A substitution at nucleotide position 206, causing the alanine (A) at amino acid position 69 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at